Cucumber mosaic cucumovirus (CMV) infects a very wide range of plant species (>1000 species). We recently demonstrated that a previously undescribed gene (2b) encoded by RNA 2 of the tripartite RNA genome of CMV is required for systemic virus spread and disease induction in its hosts. Herein we report that when this CMV gene is replaced by its homologue from tomato aspermy cucumovirus (TAV), the resultant hybrid virus is significantly more virulent, induces earlier onset of systemic symptoms, and accumulates to a higher level in seven host species from three families than either of the parents. Our results indicate that CMV and the TAV 2b protein interact synergistically despite the fact that no synergism occurs in double infections with the two parental viruses. To our knowledge, this is the first example of an interspecific hybrid made from plant or animal RNA viruses that is more efficient in systemic infection ofa number of hosts than the naturally occurring parents. As CMV and the hybrid virus accumulated to a similar level in the infected tobacco protoplasts, the observed synergistic responses most likely resulted from an increased efficacy of the hybrid virus in systemic spread in host plants provided by the TAV 2b protein.
the resultant hybrid virus is significantly more virulent, induces earlier onset of systemic symptoms, and accumulates to a higher level in seven host species from three families than either of the parents. Our results indicate that CMV and the TAV 2b protein interact synergistically despite the fact that no synergism occurs in double infections with the two parental viruses. To our knowledge, this is the first example of an interspecific hybrid made from plant or animal RNA viruses that is more efficient in systemic infection ofa number of hosts than the naturally occurring parents. As CMV and the hybrid virus accumulated to a similar level in the infected tobacco protoplasts, the observed synergistic responses most likely resulted from an increased efficacy of the hybrid virus in systemic spread in host plants provided by the TAV 2b protein.
The relevance of our finding to the application of pathogenderived resistance is discussed.
Virulence is undoubtedly an agroeconomically important property of plant viruses. However, the mechanisms by which viruses induce disease symptoms are poorly understood. Efficient infection by in vitro-transcribed RNAs (1) or directly by plasmid DNAs (2) of full-length cDNA clones of plant RNA viruses has made it possible to manipulate RNA genomes and to investigate the molecular basis of pathogenicity and virulence. In recent years, mutations introduced into various regions of the viral genome have been found to influence symptom expression. These include mutations in regions of the viral genome coding for the viral replicase (3) (4) (5) (6) , movement protein (7) (8) (9) , and coat protein (10) (11) (12) , as well as in the 5' (13) or 3' (14) nontranslated regions.
We have recently discovered (15) a small overlapping gene (2b) encoded by RNA 2 of the tripartite RNA genome of all cucumoviruses sequenced to date that is absent in closely related viruses such as the bromoviruses. The open reading frame 2b (ORF 2b; Fig. la ) located at the 3' end of RNA 2 overlaps, but is out of frame with, the C-terminal region of ORF 2a encoding the viral RNA polymerase protein. The in vivo expression of the 2b gene, most likely through the subgenomic mRNA RNA 4A (Fig. la) , has been shown for both CMV and TAV cucumoviruses (unpublished data; ref. 15) .
A recent mutational analysis has shown that the 2b gene of CMV facilitates long-distance movement of the virus throughout infected plants and that 2b is an important virulence determinant in cucumber and Nicotiana glutinosa (16) . We herein report that replacing the 2b gene of CMV with its homologue from TAV transforms a poorly virulent CMV strain into a hybrid virus that is very virulent in all seven plant species tested. To our knowledge, this is the first example of an interspecies hybrid made from plant or animal RNA viruses that is more efficient in systemic infection of a number of hosts than the parental viruses.
MATERIALS AND METHODS
Plasmid Constructs. Plasmids pQCD1, pQCD2, and pQCD3 used for efficiently producing CMV infection have been described (2) . Plasmid pQCD2qt, a derivative of pQCD2, was obtained using three overlapping PCR fragments I, II, and III (boxed with dotted line, Fig. lb 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Preparation and Transfection of Tobacco Protoplasts. Exponentially growing tobacco NT-1 suspension cells (N. tabacum) were used to prepare protoplasts as described (19) . From 300,000 to 400,000 protoplasts were transfected using a PEG method (20) by 4 ,ug of RNA isolated from purified virions. The protoplasts were collected immediately after transfection and washing or after incubation in the protoplast incubation medium (19) for 24 h at 26°C in dark, and protoplast RNAs were extracted using TRIzol reagent (GIBCO/BRL) and examined by Northern blot analysis.
RESULTS
We have shown (16) Fig. lb and was the same as that of pQCD2 (the wild-type CMV RNA 2 cDNA clone) except for the ORF 2b coding sequence, which was from TAV. The amino acid sequences encoded by ORF 2b of TAV and CMV are 22.6% identical, the most different pair of known cucumoviruses (15) .
Characterization of the Hybrid Virus in the Infected Tobacco (N. tabacum) Plants. pQCD2qt, like pQCD2, was biologically active when coinoculated with pQCD1 and pQCD3 (the wild-type cDNA clones of CMV RNAs 1 and 3) as the resultant hybrid virus (CMV-qt) accumulated in systemically infected leaves (upper uninoculated leaves) of the inoculated tobacco plants (Fig. 2a, lane 3) . To examine the nature of the progeny RNA 2, total RNAs were extracted from systemic leaves 12 days after inoculation and parallel Northern blot hybridization reactions were done using cRNA probes specific for the 3' ends of all CMV positive-strand RNAs (Fig. 2a) and for the positive strands of the TAV 2b gene (Fig. 2d) An antiserum, raised essentially as described (15) against the TAV 2b protein that was fused with glutathione S-transferase and produced in Escherichia coli, detected the 2b protein of 14 kDa in the TAV-infected plants by Western (Fig. 3a) . However, tobacco plants infected with CMV-qt showed severe symptoms (Fig.  3a) ; leaves were distorted and the plants were dwarfed. At later stages of infection, the infected plants produced fern-leaf symptoms. CMV-qt was also significantly more virulent than TAV, although TAV induced clearly visible symptoms as it also did in P. floridana ( Fig. 3b; see below) . Importantly, CMV-qt induced systemic symptoms to appear rapidly, at least 3 days earlier than those induced by TAV. Further, the genomic RNAs of CMV-qt clearly accumulated to a much greater concentration in infected tobacco plants than did those of CMV (Fig. 2a, compare lanes 2 and 3) . This increase in viral RNA accumulation correlates with the hypervirulence of CMV-qt.
The molecular basis of increased viral RNA accumulation in infected plants was followed in tobacco protoplasts inoculated with RNAs prepared from purified viral particles of CMV and CMV-qt. Infectious plasmid DNAs were not used because viral RNA transcripts must first be transcribed from these plasmids, presumably in the nuclei, and transported back to the cytoplasm before a normal cycle of viral gene expression/ replication can begin; these additional processes may have an effect on the profile of virus replication if monitored for only a short period after inoculation. Northern blot analysis of total RNAs extracted from the protoplasts immediately after inoculation detected only trace amounts of viral genomic RNAs. However, after a 24-h incubation at 26°C, a significant amount of viral genomic and subgenomic RNAs accumulated in the protoplasts that had been inoculated with CMV virion RNAs (Fig. 2c, lane 11) , showing that the introduced viral RNAs replicated in these protoplasts. Clearly, CMV-qt (lane 12) and CMV (lane 11) accumulated RNA to a similar level, thus, indicating that the greater amount of CMV-qt RNAs compared with CMV RNAs in infected plants was unlikely to result from differences in the relative rates of virus replication.
The Unusual Properties of the Hybrid Virus Result from a Synergistic Interaction Between CMV and the TAV 2b Protein.
As ORF 2b overlaps ORF 2a, the TAV RNA sequence of the hybrid RNA 2 derived from pQCD2qt was expected to be translated in two reading frames and give the TAV 2b protein, as well as the C-terminal 41 amino acids of the 92-kDA chimeric 2a protein (Fig. lb) . Therefore, two mutants of pQCD2qt were constructed to determine whether the unusual properties of CMV-qt (hypervirulence, increased accumulation, and rapid appearance of systemic symptoms) were caused by (i) the TAV 2b protein, (ii) the chimeric 2a protein, or (iii) the TAV RNA sequence. A stop codon was introduced in ORF 2a immediately to the 5' side of the TAV sequence of pQCD2qt to yield pQCD2qtl (Fig. lb) . The second codon (GCA) of ORF 2b in pQCD2qtl was further changed to a stop codon (UAA) to give pQCD2qt2 (Fig. lb) . CMV-qtl (derived from inoculum pQCD2qtl + pQCD1 + pQCD3) also induced the rapid appearance of severe systemic symptoms in tobacco (Fig. 3a) and was thus phenotypically similar to CMV-qt. In contrast, CMV-qt2 (derived from inoculum pQCD2qt2 + pQCD1 + pQCD3) was similar in virulence to CMV and caused poorly visible symptoms in tobacco. Further, CMV-qtl, like CMV-qt, accumulated to a much greater concentration than CMV did in infected tobacco (Fig. 2a , compare lanes 3 and 4 with lane 2) in spite of a similar level of accumulation of all viruses in infected protoplasts (Fig.  2c) . Therefore, the unusual properties of CMV-qt correlated directly with the expression of the TAV 2b protein that was regulated by the cis-acting elements of CMV. These results indicate that it was the synergistic interaction of the TAV 2b protein, not the inserted RNA or the chimeric 2a protein, with CMV (devoid of its own 2b) that led to the hypervirulence of CMV-qt. However, plants that were doubly infected with the Protoplast infection experiments also indicated that the C-terminal overlapping portion of the 2a protein (Fig. lb) was not required for viral replication because a similar amount of viral RNA accumulated in protoplasts ( Species from Three Families. The susceptibility of six additional host species belonging to three families (Table 2) was tested to determine whether the synergistic responses associated with CMV-qt infection were specific to particular host species. CMV did not cause obvious symptoms to any of the hosts listed in Table 2 except N. glutinosa although it infected them all. TAV induced clearly visible symptoms in P. floridana, L. esculentum, and N. glutinosa ( Fig. 3b for P. floridana; data not shown) in addition to N. tabacum as described above. The results obtained, as summarized in Table 2 , showed that CMV-qt induced rapid appearance of severe systemic symptoms ( Fig. 3b for P. floridana) and the viral RNAs accumulated to high levels (Fig. 2b, lane 8 for P. floridana) in all of these plants. Thus, these six host species responded to CMV-qt infection in the same way as the tobacco plants as described above. In the host species that displayed visible symptoms when infected with CMV or TAV (Table 2), the systemic symptoms induced by CMV-qt were significantly more severe (Fig. 3b ) and appeared at least 3 days earlier than those caused by infection with the parental viruses. The observed features of the CMV-qt infection in N. glutinosa also indicate that the TAV 2b gene is functionally similar to the 2b gene of CMV since a CMV mutant expressing no 2b protein induced a delayed appearance of the very mild systemic symptoms in this host compared with wild-type CMV (16) .
Further infection experiments were done with these six hosts using the mutants CMV-qt, CMV-qtl, and CMV-qt2. The results obtained agreed with those from infection experiments in tobacco plants described above (Figs. 2a and 3a) in that the hypervirulence and enhanced accumulation of CMV-qt RNAs in infected plants correlated with the expression of TAV 2b protein because CMV-qtl ( Fig. 2b for P. floridana), but not CMV-qt2, accumulated to high levels and induced rapid appearance of severe systemic symptoms ( Fig. 3b for P. floridana) in all of the six hosts. This is also consistent with our finding (16) that the 2b protein of CMV is essential but that the overlapping C-terminal portion of protein 2a is dispensable for symptom expression of CMV in N. glutinosa and cucumber.
DISCUSSION
The genome structure of the hybrid virus (CMV-qt) described in this report is identical to that of CMV except for the small overlapping gene 2b. This gene was transferred from TAV and constitutes only 3.3% of the complete CMV-qt genome. We have shown that CMV-qt was significantly more virulent and induced earlier onset of systemic symptoms than either of the parental viruses in seven plant species belonging to three families (Table 2) . CMV-qt RNAs clearly accumulated to a higher level in the infected plants than did those of CMV (Fig.  2) . To our knowledge, this is the first example of an interspecies hybrid made from plant (21) (22) (23) (24) or animal (25) (26) (27) RNA viruses that is more efficient in systemic infection of a number of hosts than the naturally selected parents. We are currently determining whether CMV-qt is also more competitive than its parental viruses and becomes the dominant isolate when plants are doubly infected with CMV-qt and CMV or TAV.
Our results indicate that the hypervirulence of CMV-qt most likely resulted from a synergistic interaction between the TAV 2b protein and CMV (or precisely, CMV in the absence of its own 2b). It is known that certain plant viruses can interact with each other synergistically leading to enhanced virulence (28) . However, as double infection with CMV and TAV induced no synergistic response, the interaction we observed represents a new type of virus synergism; namely, one plant virus can interact synergistically with a protein derived from a second virus and encoded in cis even though no virus synergy occurs in double infections. What is the molecular basis of the observed synergism?
Infection experiments in tobacco protoplasts showed that substituting the 2b gene in RNA 2 of CMV with that of TAV had no detectable effect on accumulation of the genomic RNAs 1 and 3 of CMV, indicating that the synergism was unrelated to changes in viral replication. The TAV 2b protein may act as a cytotoxin, thus, contributing to the hypervirulence of CMV-qt. However, this seems unlikely since the toxicity theory alone would not explain the increased accumulation of CMV-qt in infected plants.
It is most likely that the TAV 2b protein is functionally superior to the CMV 2b protein in facilitating virus movement within the plant, at least in the host species examined, and as a result, the hybrid virus spreads much more quickly in infected plants. This is partly supported by differences in the timing when N. glutinosa plants first showed systemic symptoms after inoculation with CMV-qt or CMV since CMV-qt induced the appearance of systemic symptoms at least 3 days earlier than did CMV. The 2b gene of CMV has been shown to encode a long-distance virus movement function (16) ; thus, it is highly likely that its homologue encoded by TAV has a similar function. As all seven species examined are also hosts of TAV (Table 2) , the 2b gene from TAV should have been well adapted to function in these hosts. Moreover, it is considered that symptom severity is largely determined by the relative rate of virus movement and the rate of plant growth (29) ; further, efficient virus movement will lead to an increased number of cells being infected and thus to increased viral accumulation. It has been shown that single amino acid changes in the movement proteins of other plant RNA viruses can dramatically alter both viral accumulation and virulence (8, 30) . Therefore, the synergistic responses associated with CMV-qt infection, including hypervirulence, enhanced virus accumulation, and rapid appearance of systemic symptoms, can all result from an increased speed of CMV-qt systemic spread through infected plants compared with CMV.
CMV-qt was also much more virulent than TAV, one of the parent viruses of CMV-qt. This is most likely to result from a greater amount of the TAV 2b protein being expressed by the CMV-qt genome than by the TAV genome as was shown by Western blot analysis (unpublished data). As shown in Fig. 2d , a greater amount of the chimeric RNA 4A (mRNA of 2b) accumulated in plants infected with CMV-qt (lane 16) than that of RNA 4A in the TAV-infected plants (lane 17) . This may reflect the relative strength of the CMV and TAV subgenomic RNA promoters (15) controlling transcription of RNA 4A from RNA 2. This difference in the amount of the TAV 2b protein produced by TAV and by CMV-qt may also explain why no synergistic interaction occurred in double infection with CMV and TAV where expression of the TAV 2b protein was controlled by TAV genome.
Several control strategies utilize transgenic expression of viral proteins (e.g., coat protein, replicase, and movement proteins) to protect transgenic plants from infection by the source virus (31) . Our finding raises an important point in utilizing these types of transgenic resistance since functional viral proteins expressing from transgenic plants may interact synergistically with heterologous invading viruses in the field. This type of virus synergism would make the transgenic plants more severely affected than the nontransgenic plants. Two reports further indicate that this synergism can occur in transgenic plants; it has been most recently shown that part of the potyviral genome expressed from transgenic plants is sufficient to induce the known potato virus X/potyviral synergistic disease (32) and that the disease development of CMV was accelerated in transgenic tobacco plants expressing the movement protein of tobacco mosaic virus (33) . However, such potential interactions can be readily examined in risk assessment trials.
